Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.

[1]  H. Tilg,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.

[2]  Laurent Beaugerie,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. , 2006, Journal of Crohn's & colitis.

[3]  C. Bernstein,et al.  A Population-Based Study of Breastfeeding in Inflammatory Bowel Disease: Initiation, Duration, and Effect on Disease in the Postpartum Period , 2009, The American Journal of Gastroenterology.

[4]  R. Holman,et al.  Infectious disease hospitalizations in the United States. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  C. J. van der Woude,et al.  Azathioprine treatment during lactation , 2009, Alimentary pharmacology & therapeutics.

[6]  B F Warren,et al.  European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. , 2008, Journal of Crohn's & colitis.

[7]  A. Goldman.  The immune system in human milk and the developing infant. , 2007, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[8]  C. O'Morain,et al.  Review article: reproduction in the patient with inflammatory bowel disease , 2007, Alimentary pharmacology & therapeutics.

[9]  C. Nelson-Piercy,et al.  Azathioprine and breastfeeding—is it safe? , 2007, BJOG : an international journal of obstetrics and gynaecology.

[10]  U. Klotz,et al.  Thiopurine Treatment in Inflammatory Bowel Disease , 2007, Clinical pharmacokinetics.

[11]  U. Klotz,et al.  Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. , 2007, Clinical pharmacokinetics.

[12]  G. Koren,et al.  Breast-Feeding During Maternal Use of Azathioprine , 2006, The Annals of pharmacotherapy.

[13]  R. Gearry,et al.  Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. , 2006, British journal of clinical pharmacology.

[14]  K. Michaelsen,et al.  Breast feeding and future health , 2006, Current opinion in clinical nutrition and metabolic care.

[15]  B F Warren,et al.  European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis , 2006, Gut.

[16]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[17]  J. Sauk,et al.  The use of medications for inflammatory bowel disease during pregnancy and nursing , 2005, Expert opinion on pharmacotherapy.

[18]  S. Reif,et al.  Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. , 2004, The American journal of clinical nutrition.

[19]  B. Koletzko,et al.  Nutritional and biochemical properties of human milk, Part I: General aspects, proteins, and carbohydrates. , 1999, Clinics in perinatology.

[20]  B. Koletzko,et al.  Nutritional and biochemical properties of human milk: II. Lipids, micronutrients, and bioactive factors. , 1999, Clinics in perinatology.

[21]  L. Clark,et al.  Increasing breastfeeding rates to reduce infant illness at the community level. , 1998, Pediatrics.

[22]  G. Nyberg,et al.  Breast-feeding during treatment with cyclosporine. , 1998, Transplantation.

[23]  D. Jelliffe,et al.  Breast-feeding and health in the 1980s: a global epidemiologic review. , 1991, The Journal of pediatrics.

[24]  T. Moyer,et al.  Breast-feeding after renal transplantation. , 1982, Transplantation proceedings.